Artrya Share Price and Company Fundamentals



Price
$0.285
Change
0.005 (1.786%)
52 week
0.16 - 0.42

Last traded: Yesterday at 12:58 AM

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Key Metrics

PE ratio

-

PB ratio

0.94

Dividend yield

0.00%

Beta

0.62

Market cap

-

Enterprise value

-

Company profile

Industry / Sector Health Information Services / Healthcare
Website https://www.artrya.com
Mailing address 1257 Hay Street West Perth WA 6005 Australia
Phone / Fax 61 8 6478 7816 /

Dividends

More: Artrya Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Artrya paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AYA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AYA's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of May 2024, following are the company executives and directors listed on Artrya.

Name Title Age Total Pay
Mr. Mathew Regan Chief Executive Officer 460.49k
Mr. John Konstantopoulos B.E. Co-Founder and Executive of Commercial & Strategy 287.46k
Mr. Mark Wainwright Chief Financial Officer
Prof. Girish Dwivedi M.D. Chief Scientific Officer
Mr. Ted Schwab Co-CEO of Artrya USA Inc
Mr. Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A. Company Secretary 61

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Return on assets

-23.41%

Return on equity

-39.26%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Artrya is and its enterprise value is .

The AYA's stocks Beta value is 0.62 making it 38% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Artrya (AYA)

Artrya (ASX:AYA) Frequently Asked Questions

1. What is Artrya's Stock Symbol?

Artrya trades on ASX under the ticker symbol "AYA".

2. What is Artrya's stock price today?

One share of AYA stock can currently be purchased for approximately $0.285.

3. How can I contact Artrya?

Artrya's mailing address is 1257 Hay Street West Perth WA 6005 Australia. The company can be reached via phone at 61 8 6478 7816.

4. What is Artrya's official website?

The official website of Artrya is https://www.artrya.com.